The Limited Times

Now you can see non-English news...

Pfizer has applied to FDA to start vaccinating 12 to 15 year olds Israel today

2021-04-09T18:37:37.589Z


| United States The pharmaceutical company announced on its Twitter account that it has submitted a request to the US Food and Drug Administration to vaccinate teenagers, after a study it conducted showed that the vaccine is effective and safe at these ages • Pfizer announced that it will submit similar requests to regulators around the world Pfizer vaccines for Corona // Photo: AFP Pharmaceuticals and Biontec


The pharmaceutical company announced on its Twitter account that it has submitted a request to the US Food and Drug Administration to vaccinate teenagers, after a study it conducted showed that the vaccine is effective and safe at these ages • Pfizer announced that it will submit similar requests to regulators around the world

  • Pfizer vaccines for Corona // Photo: AFP

Pharmaceuticals and Biontech, which jointly developed the corona virus vaccine, announced today (Friday) that they have submitted to the US Food and Drug Administration (FDA), the regulatory body entrusted with approving drugs and outlining their use, a request to begin vaccinating teens aged 15-12. 

According to the company's announcement, which was delivered on the social network Twitter, the company hopes to start vaccinating the new age group before the start of the 2021 school year. 

Production chain // Photo: Pfizer

Pfizer's Twitter account also states that the companies intend to forward similar requests to regulatory bodies around the world in the coming days, in order to provide the vaccine to teenagers outside the United States as well. 

At the end of March, Pfizer announced that the vaccine has been found to be effective and safe even among 15-12 year olds.

Among the boys in the current experimental group, the Pfizer vaccine showed 100 percent efficacy.

The company then announced that it intends to submit to the FDA the data it has collected on the effectiveness and safety of the vaccine among these age groups as soon as possible, in order to expand the emergency clearance granted by the US authorities.

In tests conducted by the company in the third phase of the safety and efficacy trials of the vaccine, evidence of antibody development was found among 2,260 participants aged 15-12 in the United States one month after receiving the second dose of the vaccine. Of the company at the age of 25-16.

Source: israelhayom

All news articles on 2021-04-09

You may like

Trends 24h

News/Politics 2024-03-28T06:04:53.137Z

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.